Hydrogen Patch Helps Repair Spinal Cord Injuries in Mice
- Authors
- Yuanqing Ding, Yihan Chen, Yiming Tao, Zezhen Zhang, Min Ge, Jianlin Shi, Han Lin, Rong Xie
- Journal
- ACS Nano
- Year
- 2026
- DOI
- 10.1021/acsnano.5c19206
- Study Type
- Mouse
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Spinal Cord Injury
- Body System
- Nervous System
TL;DR
A hydrogen-releasing, iron-scavenging microneedle patch reduced ferroptosis-related injury and improved locomotor recovery in a mouse model of spinal cord injury.
Key Finding
A microneedle patch that releases hydrogen gas and chelates iron reduced intracellular iron levels by 46.7% and significantly improved locomotor recovery in mice with spinal cord injury.
Summary
Researchers developed a special patch containing tiny needles that delivers two therapeutic substances to treat spinal cord injury in mice. The patch releases iron-scavenging molecules (which bind to excess iron) and hydrogen gas, both of which work to reduce oxidative stress (cellular damage from harmful molecules). In mouse studies, the patch reduced iron buildup in the spinal cord and improved movement recovery.
Practical Takeaway
This is early-stage research in mice only, not humans. While the results are promising for spinal cord injury treatment, the patch is an experimental medical device, not a hydrogen water product. The hydrogen delivery mechanism here (sustained release from ammonia borane in a microneedle patch) is fundamentally different from drinking hydrogen water, so these findings do not directly apply to hydrogen water consumption.
Abstract
Spinal cord injury (SCI) is a devastating trauma to the central nervous system, causing permanent functional nerve defects. A key therapeutic challenge is the inhibition of the secondary injury cascade, specifically the progressive neural damage from iron overload-induced ferroptosis and oxidative stress. To target these dual mechanisms, we developed a dual-functional, iron-scavenging, and hydrogen-releasing microneedle patch (MN/MON@AB) composed of ammonia borane (AB)-loaded, amino-functionalized mesoporous organosilica nanoparticles (MON-NH2) embedded in a biodegradable silk fibroin array. This system functions via a dual-target mechanism: amino groups chelate excess iron ions to suppress the Fenton reaction, while AB provides sustained release of molecular hydrogen (H2) in the acidic injury microenvironment to neutralize reactive oxygen species (ROS). MN/MON@AB has been found to reduce the intracellular Fe2+ levels by 46.7%, nearly doubling the expression of the key ferroptosis regulator GPX4, and largely alleviating lipid peroxidation in vitro. In a murine SCI model, the patch significantly reduced spinal iron deposition (p < 0.0001) and promoted marked locomotor recovery (p < 0.001). Featuring combined localized iron chelation and sustained antioxidant delivery, the present strategy offers a broadly applicable and pioneering therapeutic platform for treating acute neural injuries and subsequent neurodegenerative processes.